98%
921
2 minutes
20
Background: Vibrio parahaemolyticus in seafood poses a major public health concern, particularly in tropical regions.
Objective: The present study aims to isolate, assess antibiotic susceptibility, and determine the biofilm-forming ability of V. parahaemolyticus strains isolated from seafood sold in Cochin, India.
Methods: One hundred seafood samples were collected from retail markets in Cochin and analyzed for V. parahaemolyticus. Phenotypic identification was confirmed through biochemical assays and molecular characterization using polymerase chain reaction (PCR) targeting toxR, tdh, and trh genes. Biofilm formation was assessed using the microtiter plate-crystal violet assay, and antibiotic resistance was determined using the disc diffusion method.
Results: V. parahaemolyticus was detected in 43.0% (43/100) of the total seafood analyzed. A total of 43 isolates were confirmed by the toxR gene, of which five carried the tdh gene, while none harbored the trh gene. Antimicrobial susceptibility testing revealed 100% resistance to ampicillin, whereas all isolates were fully susceptible to chloramphenicol. The multiple antibiotic resistance (MAR) index ranged from 0.13 to 0.50. Notably, some multidrug-resistant isolates exhibited strong biofilm formation at 37°C.
Conclusion: The high prevalence of antibiotic-resistant V. parahaemolyticus in seafood sold in Cochin and their ability to form biofilms underscores the need for rigorous monitoring and effective control strategies to safeguard public health.
Highlights: The overall prevalence of V. parahaemolyticus in seafood from the retail market was 43.0%. The tdh gene was detected in five isolates, and none had the trh gene. All isolates exhibited resistance to ampicillin and were fully susceptible to chloramphenicol. The MAR index ranged from 0.13 to 0.50.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jaoacint/qsaf037 | DOI Listing |
Emerg Med Australas
October 2025
Emergency and Trauma Centre, The Alfred Hospital, Melbourne, Victoria, Australia.
Objectives: Acute pyelonephritis (APN) is a common diagnosis among patients presenting to the Emergency Department (ED). It is treated by empiric antibiotics within the ED. With a rise in antimicrobial resistance globally, it is unknown whether patients are being managed with empiric antibiotics that are appropriate for the causative organisms of APN.
View Article and Find Full Text PDFMicrob Drug Resist
September 2025
Drug Discovery Research, Wockhardt Research Centre, Wockhardt Ltd., Chhatrapati Sambhajinagar, India.
Cefepime (FEP), a fourth-generation cephalosporin combined with tazobactam (TAZ), a β-lactamase inhibitor, is being developed by Wockhardt as a pharmacodynamically optimized fixed dose combination (FEP-2 g + TAZ-2 g) for the treatment of multidrug-resistant Gram-negative infections. To undertake an exposure-response analysis for establishing pharmacokinetic (PK)/pharmacodynamic (PD) targets, it is crucial to characterize the PK profile of compounds in surrogate compartments, such as plasma and lung, in clinically relevant animal infection models used to evaluate efficacy. In the current study, PKs of FEP and TAZ were assessed in plasma and in epithelial lining fluid (ELF) of neutropenic noninfected, lung-infected, and thigh-infected mice.
View Article and Find Full Text PDFSurg Infect (Larchmt)
September 2025
Department of Surgery, Division of Acute Care Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
Patients with traumatic injuries who develop ventilator-associated pneumonia (VAP) incur a higher risk of developing multi-drug resistance. Shorter duration of antibiotic agents for early VAP at five days may reduce antibiotic agent exposure without worsening patient outcomes. This retrospective cohort study performed at a Level I Trauma Center included adult (≥16 years old) patients with trauma diagnosed with bronchoalveolar lavage (BAL)-proven early (within four days of intubation) bacterial VAP.
View Article and Find Full Text PDFOpen Res Eur
September 2025
Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, 1870, Denmark.
Background: Innovative antibiotic discovery strategies are urgently needed to successfully combat infections caused by multi-drug-resistant bacteria.
Methods: We employed a direct screening approach to identify compounds with antimicrobial and antimicrobial helper-drug activity against Gram-positive and Gram-negative bacteria. We used this platform in two different strains of methicillin-resistant (MRSA) and aminoglycoside-resistant strains of to screen for antimicrobials compounds, which potentiate the activity of aminoglycoside antibiotics.
Philos Trans A Math Phys Eng Sci
September 2025
D-BAUG, ETH Zurich, Zürich 8093, Switzerland.
Biofilms-microbial communities encased in a self-produced extracellular matrix-pose a significant challenge in clinical settings due to their association with chronic infections and antibiotic resistance. Their formation in the human body is governed by a complex interplay of biological and environmental factors, including the biochemical composition of bodily fluids, fluid dynamics, and cell-cell and cell-surface interactions. Improving therapeutic strategies requires a deeper understanding of how host-specific conditions shape biofilm development.
View Article and Find Full Text PDF